Dear OncoLink "Ask The Experts,"
I was diagnosed with fallopian cancer January 2006 had surgery and 6 chemo treatments ending July 2006. My Gynecologic Oncologist ordered a PET/CT in February 2007. My insurance company is refusing to pay for the scan saying it is not a proven for my type of cancer. I'm looking for research data that will support the use of PET/CT in fallopian/ovarian cancer.
Stephen C. Rubin, MD, Professor and Chief of the Division of Gynecologic Oncology, University of Pennsylvania Health System, responds:
At present, there is no convincing data that using PET/CT scans will improve the outcome for women with ovarian cancer. In other words, finding recurrence on a PET/CT when no symptoms are present (pain, elevated CA-125, etc) may not result in any improvement in survival. This was found to be true in breast cancer and guidelines state that those patients should have radiology scans (CT, bone scans, etc) only if symptoms arise. Many insurance companies will not pay for the PET/CT test, as it is quite expensive and there is a fair amount of uncertainty as to its value in improving patient outcomes.
May 14, 2014 - The use of positron emission tomography combined with computed tomography (PET-CT) compared with CT rarely impacts surgical management for patients with potentially resectable hepatic metastases of colorectal adenocarcinoma, according to a study published in the May 14 issue of the Journal of the American Medical Association.
May 16, 2012
Sep 27, 2010
Mar 12, 2014